Terms: = Ovarian cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
129 results:
1. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
2. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms.
Wang Y; Wen J; Sun X; Sun Y; Liu Y; Cheng X; Wu W; Liu Q; Ren F
Cancer Chemother Pharmacol; 2024 Apr; 93(4):295-306. PubMed ID: 37938423
[TBL] [Abstract] [Full Text] [Related]
3. Validation of a New Prognostic Score in Patients with ovarian Adenocarcinoma.
Trifanescu OG; Mitrica RI; Gales LN; Marinescu SA; Motas N; Trifanescu RA; Rebegea L; Gherghe M; Georgescu DE; Serbanescu GL; Bashar HH; Dragosloveanu S; Cristian DA; Anghel RM
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837431
[No Abstract] [Full Text] [Related]
4. In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous ovarian cancer Cell Lines via Attenuating MAPK Signaling Pathway.
Fawzy MA; Abu-Baih RH; Abuo-Rahma GEA; Abdel-Rahman IM; El-Sheikh AAK; Nazmy MH
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770806
[TBL] [Abstract] [Full Text] [Related]
5. [Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer].
Zong LJ; Xiang Y; Yu SN; Lu ZH; Chen J; Huang WH
Zhonghua Fu Chan Ke Za Zhi; 2022 Dec; 57(12):921-931. PubMed ID: 36562226
[No Abstract] [Full Text] [Related]
6. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic bcl2L12.
Wang Z; Wang S; Qin J; Zhang X; Lu G; Liu H; Guo H; Wu L; Shender VO; Shao C; Kong B; Liu Z
Nat Commun; 2022 Oct; 13(1):6246. PubMed ID: 36271053
[TBL] [Abstract] [Full Text] [Related]
7. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract] [Full Text] [Related]
8. Isolation, Characterization, and Autophagy Function of BECN1-Splicing Isoforms in cancer Cells.
Maheshwari C; Vidoni C; Titone R; Castiglioni A; Lora C; Follo C; Isidoro C
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008963
[TBL] [Abstract] [Full Text] [Related]
9. The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW; Xue H; Ha MW; Yu DY; Xiao LJ; Zheng HC
J Obstet Gynaecol; 2022 Oct; 42(7):3149-3157. PubMed ID: 35929918
[TBL] [Abstract] [Full Text] [Related]
10. Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed ovarian cancer: A Real-World Evidence Study.
Kim SI; Lim H; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Lee M
Cancer Res Treat; 2023 Jan; 55(1):245-257. PubMed ID: 35879854
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-Suppressor Gene Transmembrane Protein 98 Promotes Proliferation and Inhibits Apoptosis in ovarian cancer.
Wu SG; Xu JY; Lei J; Hu M; Zhou J
Front Biosci (Landmark Ed); 2022 Jun; 27(7):210. PubMed ID: 35866395
[TBL] [Abstract] [Full Text] [Related]
12. Prohibitin 1 interacts with p53 in the regulation of mitochondrial dynamics and chemoresistance in gynecologic cancers.
Kong B; Han CY; Kim SI; Patten DA; Han Y; Carmona E; Shieh DB; Cheung AC; Mes-Masson AM; Harper ME; Song YS; Tsang BK
J Ovarian Res; 2022 Jun; 15(1):70. PubMed ID: 35668443
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma.
Zhong L; Liu X; Wang L; Liu Y; Zhang D; Zhao Y
J Ovarian Res; 2022 Jan; 15(1):7. PubMed ID: 35027053
[TBL] [Abstract] [Full Text] [Related]
14. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.
Ma C; Liu M; Zhang J; Cai H; Wu Y; Zhang Y; Ji Y; Shan H; Zou Z; Yang L; Liu L; Xu H; Lei H; Liu C; Zhou L; Cao Y; Zhou H; Wu Y
Chem Biol Interact; 2022 Jan; 351():109770. PubMed ID: 34861246
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract] [Full Text] [Related]
16. Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma.
Matsumoto T; Yoki A; Konno R; Oguri Y; Hashimura M; Tochimoto M; Nakagawa M; Jiang Z; Ishibashi Y; Ito T; Kodera Y; Saegusa M
Carcinogenesis; 2021 Oct; 42(9):1162-1170. PubMed ID: 34323956
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of Twenty Genes in prognosis of Patients with ovarian cancer Using Four Different Clustering Methods.
Pourahmad S; Foroozani S; Nourelahi M; Hosseini A; Razmkhah M
Asian Pac J Cancer Prev; 2021 Jun; 22(6):1781-1787. PubMed ID: 34181334
[TBL] [Abstract] [Full Text] [Related]
18. The lncRNA 'UCA1' modulates the response to chemotherapy of ovarian cancer through direct binding to miR-27a-5p and control of UBE2N levels.
Wambecke A; Ahmad M; Morice PM; Lambert B; Weiswald LB; Vernon M; Vigneron N; Abeilard E; Brotin E; Figeac M; Gauduchon P; Poulain L; Denoyelle C; Meryet-Figuiere M
Mol Oncol; 2021 Dec; 15(12):3659-3678. PubMed ID: 34160887
[TBL] [Abstract] [Full Text] [Related]
19. Umbilical metastases: Real-world data shows abysmal outcome.
Hugen N; Kanne H; Simmer F; van de Water C; Voorham QJ; Ho VK; Lemmens VE; Simons M; Nagtegaal ID
Int J Cancer; 2021 Sep; 149(6):1266-1273. PubMed ID: 33990961
[TBL] [Abstract] [Full Text] [Related]
20. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway.
Zhao F; Hong X; Li D; Wei Z; Ci X; Zhang S
Med Oncol; 2021 Apr; 38(5):54. PubMed ID: 33811596
[TBL] [Abstract] [Full Text] [Related]
[Next]
